Clinical Trial Update: A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicating AB-1003 is being studied in Phase 1/2 in individuals with genetically confirmed LGMD2I (FKRP-related limb-girdle muscular dys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb Girdle Muscular Dystrophy
• Limb-girdle Muscular Dystrophy Type 2i
• Muscular Dystrophy

Drugs mentioned

• AB-1003

Snippet

Sponsor: AskBio Inc | Conditions: Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2 | Phase 1, Phase 2 | Status: RECRUITING